By debunking some common myths about breast cancer, two oncologists from the US hope to give women some simple key messages to help them understand and manage their risk of breast cancer…
No Comments »
Filed under: Women's Health
WASHINGTON (MedPage Today) — The FDA approved the over-the-counter sale of a line of fexofenadine (Allegra) allergy drugs.
No Comments »
Filed under: General Health News
(MedPage Today) — The American Medical Association has initiated a new effort to help physicians who have left clinical medicine return to active practice if they wish.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — President Barack Obama told members of Congress and the nation that he is unwilling to repeal the healthcare reform bill but is willing to “fix what needs fixing,” during his second State of the Union address Tuesday night.
No Comments »
Filed under: General Health News
(MedPage Today) — GAITHERSBURG, Md. — A federal advisory panel has called for stricter regulatory controls on automated external defibrillators (AEDs) as part of the FDA’s push to re-examine the classification of some of its riskier devices.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has approved a generic version of the pantoprazole delayed-release tablets (Protonix DR) to treat gastroesophageal reflux disease.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA approved the over-the-counter sale of a line of fexofenadine (Allegra) allergy drugs.
No Comments »
Filed under: Pharmacy News
(MedPage Today) — GE Healthcare has settled a bellwether product liability suit involving its gadolinium-based MRI contrast agent gadodiamide (Omniscan).
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — The FDA has approved a generic version of the pantoprazole delayed-release tablets (Protonix DR) to treat gastroesophageal reflux disease.
No Comments »
Filed under: Pharmacy News
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced that the company’s new manufacturing facility in Penang Island, Malaysia has received European CE Mark approval for production of pacemakers and leads. The first products have already been shipped to the company’s distribution center in Veddesta, Sweden…
No Comments »
Filed under: Pharmacy News
